High Tower Advisors, LLC Allogene Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,556 shares of ALLO stock, worth $76,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,556

Previous 30,556 -0.0%

Holding current value

$76,695

Previous $136,000 47.79%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$2.92 - $5.63 $14,600 - $28,150	5,000 Added 19.56%	30,556 $136,000
Q4 2023 Feb 12, 2024	SELL	$2.28 - $3.5 $69,090 - $106,060	-30,303 Reduced 54.25%	25,556 $82,000
Q3 2023 Nov 08, 2023	SELL	$3.17 - $5.96 $1,483 - $2,789	-468 Reduced 0.83%	55,859 $177,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $2,409 - $3,585	-532 Reduced 0.94%	56,327 $279,000
Q1 2023 May 11, 2023	SELL	$4.92 - $8.21 $2,400 - $4,006	-488 Reduced 0.85%	56,859 $280,000
Q4 2022 Feb 08, 2023	SELL	$5.62 - $11.11 $60,201 - $119,010	-10,712 Reduced 15.74%	57,347 $360,000
Q2 2022 Aug 10, 2022	BUY	$6.78 - $12.28 $118,650 - $214,900	17,500 Added 34.61%	68,059 $776,000
Q1 2022 May 12, 2022	SELL	$7.65 - $15.29 $229 - $458	-30 Reduced 0.06%	50,559 $462,000
Q4 2021 Feb 10, 2022	SELL	$13.13 - $24.52 $16,018 - $29,914	-1,220 Reduced 2.35%	50,589 $753,000
Q3 2021 Nov 12, 2021	BUY	$21.01 - $27.64 $115,555 - $152,020	5,500 Added 11.88%	51,809 $1.33 Million
Q2 2021 Aug 06, 2021	SELL	$23.49 - $35.8 $46,980 - $71,600	-2,000 Reduced 4.14%	46,309 $1.21 Million
Q4 2020 Feb 10, 2021	BUY	$25.24 - $43.45 $97,174 - $167,282	3,850 Added 8.66%	48,309 $1.22 Million
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $59,125 - $82,096	-1,826 Reduced 3.95%	44,459 $1.68 Million
Q2 2020 Aug 10, 2020	SELL	$18.39 - $54.04 $186,842 - $549,046	-10,160 Reduced 18.0%	46,285 $1.98 Million
Q1 2020 May 21, 2020	BUY	$18.22 - $28.25 $1.03 Million - $1.59 Million	56,445 New	56,445 $1.1 Million
Q4 2019 Feb 14, 2020	SELL	$24.82 - $31.4 $574,334 - $726,596	-23,140 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $306,479 - $387,236	11,738 Added 102.95%	23,140 $630,000
Q2 2019 Aug 13, 2019	BUY	$25.56 - $31.09 $291,435 - $354,488	11,402 New	11,402 $306,000

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

132M

Call Options Held

94.3K

Put Options Held

112K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $361M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Allogene Therapeutics, Inc. Transaction History